Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.15 trillion and total revenue of $109.89 billion.
Market Cap
1.15T
Revenue
109.89B
Profits
-41.54B
PE Ratio
n/a
Profit Margin
-37.80%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.63B | - | 2,993,021 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.05B | - | 2,609,258 | 14.92B |
| 3 | ARGX | argenx SE | 55.19B | - | 351,970 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.13B | - | 2,204,704 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 34.65B | - | 4,702,503 | - |
| 6 | RPRX | Royalty Pharma plc | 30.50B | - | 8,608,503 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 30.03B | - | 367,886 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 25.38B | 3.50% | 24,078,835 | 2.23B |
| 9 | BNTX | BioNTech SE | 22.98B | - | 939,598 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.61B | - | 8,263,245 | 8.26M |
| 11 | INSM | Insmed Incorporated | 20.76B | - | 23,379,307 | 819.56M |
| 12 | INCY | Incyte Corporation | 19.62B | - | 4,058,623 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.42B | - | 1,809,920 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.34B | - | 908,473 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.10B | - | 1,906,922 | 4.44B |
| 16 | EXEL | Exelixis, Inc. | 13.05B | - | 6,545,171 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.98B | - | 3,815,605 | 579.96M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.89B | - | 770,864 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.25B | - | 2,984,374 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.66B | - | 486,993 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.52B | - | 3,863,403 | 622.01M |
| 22 | CYTK | Cytokinetics, Incorporated | 10.70B | - | 3,547,472 | 105.82M |
| 23 | SMMT | Summit Therapeutics Inc. | 10.67B | - | 8,723,161 | - |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | - | 3,481,457 | 3.24B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.26B | - | 811,433 | 417.30M |
| 26 | NUVL | Nuvalent, Inc. | 9.75B | - | 4,603,597 | - |
| 27 | TECH | Bio-Techne Corporation | 9.07B | - | 3,773,094 | 1.21B |
| 28 | CORT | Corcept Therapeutics Incorporated | 8.58B | - | 1,875,598 | 769.10M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.13B | - | 3,654,031 | 1.51B |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | - | 698,565 | 7.46M |
| 31 | ABVX | ABIVAX Société Anonyme | 7.77B | - | 1,701,700 | 5.67M |
| 32 | IBRX | ImmunityBio, Inc. | 7.71B | 5.29% | 14,372,395 | 140.98M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 7.67B | - | 2,420,429 | - |
| 34 | TGTX | TG Therapeutics, Inc. | 7.54B | 3.34% | 7,172,563 | 700.35M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 7.44B | - | 1,262,295 | 51.48M |
| 36 | PCVX | Vaxcyte, Inc. | 7.43B | - | 2,837,044 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 7.26B | - | 1,533,672 | 74.06M |
| 38 | IMVT | Immunovant, Inc. | 7.26B | - | 3,888,369 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.77B | - | 1,970,054 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.63B | - | 1,558,968 | 217.17M |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.55B | - | 2,870,286 | 827.11M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | - | 1,576,815 | 569.61M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.19B | - | 5,588,743 | 15.00M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.90B | - | 4,898,257 | - |
| 45 | BLTE | Belite Bio, Inc | 5.75B | - | 255,109 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.67B | - | 3,059,292 | - |
| 47 | LGND | Ligand Pharmaceuticals Incorporated | 5.51B | - | 609,561 | 274.48M |
| 48 | CGON | CG Oncology, Inc. | 5.39B | - | 2,259,043 | 5.07M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.22B | - | 2,398,379 | 907.29M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.22B | 1.88% | 1,941,408 | 4.10M |
| 51 | LEGN | Legend Biotech Corporation | 5.19B | - | 13,608,396 | 1.14B |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.13B | - | 6,587,102 | 536.20M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | - | 1,927,661 | 7.50M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | - | 2,478,108 | 1.34M |
| 55 | ORKA | Oruka Therapeutics, Inc. | 4.36B | 2.06% | 2,986,885 | - |
| 56 | CELC | Celcuity Inc. | 4.28B | - | 2,126,823 | - |
| 57 | ERAS | Erasca, Inc. | 4.25B | - | 9,642,125 | - |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.05B | - | 12,095,877 | 56.99M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 3.96B | - | 2,007,584 | - |
| 60 | MANE | Veradermics, Incorporated | 3.92B | - | 826,641 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | - | 3,354,254 | 596.96M |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.78B | - | 2,013,875 | 18.07M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | - | 3,225,717 | 1.10B |
| 64 | DNLI | Denali Therapeutics Inc. | 3.70B | - | 2,518,393 | - |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.53B | - | 3,395,661 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | - | 1,250,184 | 22.57M |
| 67 | RLAY | Relay Therapeutics, Inc. | 3.46B | - | 10,738,974 | 10.68M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.45B | - | 90,462 | 803.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.40B | - | 3,509,471 | 164.01M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.29B | - | 685,074 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | - | 5,480,646 | 415.62M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.27B | - | 5,111,971 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.16B | - | 1,152,053 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.06B | - | 2,309,066 | 236.00M |
| 75 | ALMS | Alumis Inc. | 2.98B | - | 1,883,737 | 8.40M |
| 76 | QURE | uniQure N.V. | 2.92B | - | 4,859,906 | 18.09M |
| 77 | ELVN | Enliven Therapeutics, Inc. | 2.75B | - | 2,449,817 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.74B | - | 2,018,517 | 225.27M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.72B | - | 402,143 | 535.08M |
| 80 | IRON | Disc Medicine, Inc. | 2.70B | - | 1,562,335 | - |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.69B | - | 3,562,450 | 670.00M |
| 82 | DFTX | Definium Therapeutics, Inc. | 2.67B | 0.20% | 2,629,893 | - |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.58B | - | 4,355,889 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.55B | - | 2,378,576 | 865.00K |
| 85 | VERA | Vera Therapeutics, Inc. | 2.52B | - | 1,497,554 | - |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.44B | 5.13% | 2,960,142 | - |
| 87 | PHVS | Pharvaris N.V. | 2.29B | - | 182,167 | - |
| 88 | KOD | Kodiak Sciences Inc. | 2.26B | - | 1,205,936 | - |
| 89 | NTLA | Intellia Therapeutics, Inc. | 2.19B | 3.09% | 8,849,172 | 66.09M |
| 90 | IMNM | Immunome, Inc. | 2.12B | - | 3,318,516 | 4.02M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 1.98% | 1,172,338 | 298.30M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.06B | - | 6,114,283 | 52.04M |
| 93 | NKTR | Nektar Therapeutics | 2.06B | 0.10% | 909,591 | 55.63M |
| 94 | MBX | MBX Biosciences, Inc. | 2.05B | - | 832,199 | - |
| 95 | VCEL | Vericel Corporation | 2.05B | - | 1,686,309 | 292.09M |
| 96 | BHVN | Biohaven Ltd. | 2.04B | - | 6,458,979 | - |
| 97 | ZLAB | Zai Lab Limited | 2.04B | - | 978,130 | 453.28M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | - | 4,062,205 | - |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | - | 2,241,589 | 66.05M |
| 100 | KARD | Kardigan, Inc. | 1.97B | 37.50% | 5,844,442 | - |
| 101 | MESO | Mesoblast Limited | 1.96B | - | 126,036 | 65.38M |
| 102 | NUVB | Nuvation Bio Inc. | 1.94B | - | 4,730,292 | 143.05M |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.93B | - | 1,971,080 | 32.08M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | - | 770,605 | 899.11M |
| 105 | ADMA | ADMA Biologics, Inc. | 1.93B | - | 8,921,995 | 509.86M |
| 106 | LKFT | Lakefront Biotherapeutics NV | 1.86B | - | 159,488 | 1.20B |
| 107 | GENB | Generate Biomedicines, Inc. | 1.86B | 4.47% | 2,604,818 | 30.30M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 3.36% | 5,610,425 | 2.18B |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | - | 6,368,906 | 7.47M |
| 110 | VRDN | Viridian Therapeutics, Inc. | 1.84B | - | 4,032,028 | 70.92M |
| 111 | NRIX | Nurix Therapeutics, Inc. | 1.81B | - | 4,250,980 | 71.78M |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.79B | - | 355,436 | 20.00M |
| 113 | NBTX | Nanobiotix S.A. | 1.76B | - | 49,584 | 38.27M |
| 114 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | - | 23,714,726 | 285.61M |
| 115 | PGEN | Precigen, Inc. | 1.72B | - | 4,755,744 | 31.60M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 3.86% | 24,853,721 | 66.41M |
| 117 | ZYME | Zymeworks Inc. | 1.69B | - | 699,024 | 81.26M |
| 118 | ABCL | AbCellera Biologics Inc. | 1.69B | - | 6,803,880 | 79.21M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.68B | - | 2,561,457 | - |
| 120 | SION | Sionna Therapeutics, Inc. | 1.68B | - | 736,762 | - |
| 121 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | - | 3,994,897 | 217.17M |
| 122 | ANAB | AnaptysBio, Inc. | 1.67B | - | 827,833 | 232.39M |
| 123 | INVA | Innoviva, Inc. | 1.66B | - | 1,403,827 | 420.69M |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.64B | 1.54% | 3,095,680 | 11.13M |
| 125 | URGN | UroGen Pharma Ltd. | 1.64B | - | 847,099 | 140.49M |
| 126 | SEPN | Septerna, Inc. | 1.63B | - | 283,356 | 72.26M |
| 127 | PVLA | Palvella Therapeutics, Inc. | 1.62B | - | 383,247 | - |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | - | 2,507,724 | 42.95M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.54B | - | 8,795,300 | 65.50M |
| 130 | BCAX | Bicara Therapeutics Inc. | 1.53B | - | 1,934,590 | - |
| 131 | GHRS | GH Research PLC | 1.53B | - | 544,656 | - |
| 132 | NVAX | Novavax, Inc. | 1.50B | - | 9,458,291 | 596.34M |
| 133 | SLS | SELLAS Life Sciences Group, Inc. | 1.50B | 3.74% | 14,747,756 | - |
| 134 | ATAI | AtaiBeckley Inc. | 1.49B | - | 6,624,978 | 3.49M |
| 135 | ARDX | Ardelyx, Inc. | 1.49B | - | 9,839,094 | 427.68M |
| 136 | AAPG | Ascentage Pharma Group International | 1.48B | - | 12,802 | 82.08M |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.48B | - | 859,254 | - |
| 138 | IMCR | Immunocore Holdings plc | 1.45B | - | 812,334 | 412.81M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.45B | - | 3,008,146 | 2.71B |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.42B | - | 1,390,455 | 20.00M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.41B | 0.10% | 774,519 | - |
| 142 | SVRA | Savara Inc. | 1.39B | - | 4,761,569 | - |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.37B | - | 473,549 | 1.30M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | - | 9,280,186 | 204.73M |
| 145 | IMTX | Immatics N.V. | 1.34B | - | 438,424 | 43.00M |
| 146 | AKTS | Aktis Oncology, Inc. | 1.33B | - | 552,135 | 8.28M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.31B | - | 1,515,229 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.31B | - | 1,466,885 | - |
| 149 | DMRA | Damora Therapeutics, Inc. | 1.31B | - | 1,747,141 | - |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | - | 1,548,237 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.25B | - | 2,128,326 | 10.00M |
| 152 | MNKD | MannKind Corporation | 1.22B | - | 16,622,952 | 360.78M |
| 153 | WVE | Wave Life Sciences Ltd. | 1.19B | - | 5,099,122 | 71.80M |
| 154 | ABSI | Absci Corporation | 1.16B | - | 8,444,165 | 1.84M |
| 155 | EYPT | EyePoint, Inc. | 1.14B | - | 1,290,270 | 7.61M |
| 156 | MGTX | MeiraGTx Holdings plc | 1.05B | - | 2,519,936 | 79.76M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.75% | 1,977,181 | - |
| 158 | JBIO | Jade Biosciences, Inc. | 998.43M | - | 4,785,525 | - |
| 159 | SPTX | Seaport Therapeutics, Inc. | 972.65M | - | 1,326,804 | - |
| 160 | DBVT | DBV Technologies S.A. | 961.15M | - | 320,272 | 5.74M |
| 161 | SPRY | ARS Pharmaceuticals, Inc. | 958.28M | - | 2,277,986 | 98.99M |
| 162 | SANA | Sana Biotechnology, Inc. | 944.68M | - | 6,743,940 | - |
| 163 | XNCR | Xencor, Inc. | 937.15M | - | 1,815,287 | 97.36M |
| 164 | SLBT | SL Science Holding Limited | 935.81M | - | 488,769 | - |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 923.71M | - | 3,117,265 | - |
| 166 | PHAR | Pharming Group N.V. | 915.32M | - | 3,254 | 369.49M |
| 167 | ODTX | Odyssey Therapeutics, Inc. | 899.61M | - | 1,602,913 | 1.06M |
| 168 | ABUS | Arbutus Biopharma Corporation | 898.80M | - | 5,045,878 | 191.45M |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 892.83M | -1.47% | 3,927,187 | 69.64M |
| 170 | DRTS | Alpha Tau Medical Ltd. | 881.92M | - | 574,439 | - |
| 171 | KURA | Kura Oncology, Inc. | 881.53M | - | 1,700,093 | 71.64M |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 878.86M | - | 2,771,345 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 867.20M | - | 1,251,142 | 13.73M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 864.20M | - | 1,101,965 | 204.89M |
| 175 | LBRX | LB Pharmaceuticals Inc | 860.30M | - | 513,122 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 854.75M | - | 952,850 | 109.78M |
| 177 | REPL | Replimune Group, Inc. | 841.41M | - | 2,571,739 | - |
| 178 | OLMA | Olema Pharmaceuticals, Inc. | 830.67M | - | 2,868,788 | - |
| 179 | SLDB | Solid Biosciences Inc. | 820.09M | - | 14,768,079 | - |
| 180 | GERN | Geron Corporation | 808.32M | - | 22,995,891 | 196.12M |
| 181 | ANNX | Annexon, Inc. | 802.83M | - | 7,342,604 | - |
| 182 | ANRO | Alto Neuroscience, Inc. | 798.04M | - | 558,218 | - |
| 183 | VOR | Vor Biopharma Inc. | 785.15M | - | 2,875,027 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 776.96M | - | 1,036,689 | - |
| 185 | AVTX | Avalo Therapeutics, Inc. | 772.71M | - | 6,417,380 | 59.00K |
| 186 | EVMN | Evommune, Inc. | 769.35M | - | 665,146 | 10.00M |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 762.58M | - | 1,948,450 | 122.29M |
| 188 | OMER | Omeros Corporation | 744.02M | - | 2,634,659 | 9.89M |
| 189 | IVA | Inventiva S.A. | 727.77M | - | 3,549,809 | 7.94M |
| 190 | RLMD | Relmada Therapeutics, Inc. | 705.91M | - | 4,106,676 | - |
| 191 | AURA | Aura Biosciences, Inc. | 699.30M | - | 1,263,808 | - |
| 192 | ALLO | Allogene Therapeutics, Inc. | 690.31M | - | 23,548,239 | 22.00K |
| 193 | CRMD | CorMedix Inc. | 680.18M | - | 2,521,887 | 400.05M |
| 194 | OCS | Oculis Holding AG | 677.55M | - | 772,599 | 1.40M |
| 195 | CLYM | Climb Bio, Inc. | 655.63M | - | 1,246,874 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 642.22M | - | 9,732,497 | 35.54M |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 628.49M | - | 4,322,756 | 8.37M |
| 198 | SGP | SpyGlass Pharma, Inc. | 625.08M | - | 144,288 | - |
| 199 | IMMX | Immix Biopharma, Inc. | 620.78M | - | 7,434,821 | - |
| 200 | TENX | Tenax Therapeutics, Inc. | 613.10M | - | 2,691,091 | - |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 608.90M | - | 972,705 | 299.77M |
| 202 | CADL | Candel Therapeutics, Inc. | 608.88M | - | 8,197,173 | - |
| 203 | DRUG | Bright Minds Biosciences Inc. | 608.01M | - | 239,406 | - |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 607.83M | - | 1,915,186 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 605.61M | - | 2,293,216 | - |
| 206 | DNA | Ginkgo Bioworks Holdings, Inc. | 599.03M | - | 1,545,900 | 151.40M |
| 207 | CBIO | Crescent Biopharma, Inc. | 587.82M | - | 119,469 | 11.88M |
| 208 | PRME | Prime Medicine, Inc. | 583.39M | - | 3,501,632 | 4.03M |
| 209 | GYRE | Gyre Therapeutics, Inc. | 571.07M | - | 85,723 | 117.05M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 566.45M | - | 106,749 | - |
| 211 | PROK | ProKidney Corp. | 552.77M | - | 578,592 | 889.00K |
| 212 | MDXG | MiMedx Group, Inc. | 546.63M | - | 2,130,569 | 389.42M |
| 213 | AGMB | AgomAb Therapeutics NV | 540.74M | - | 188,963 | - |
| 214 | XOMA | XOMA Royalty Corporation | 525.34M | - | 88,326 | 48.56M |
| 215 | ALT | Altimmune, Inc. | 525.08M | - | 11,688,234 | 36.00K |
| 216 | RZLT | Rezolute, Inc. | 524.42M | - | 2,812,694 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 520.27M | - | 320,268 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 504.99M | - | 892,231 | 88.24M |
| 219 | VALN | Valneva SE | 501.36M | - | 13,050 | 180.25M |
| 220 | NGNE | Neurogene Inc. | 498.23M | - | 308,956 | 925.00K |
| 221 | ACHV | Achieve Life Sciences, Inc. | 497.90M | - | 6,945,503 | - |
| 222 | ARVN | Arvinas, Inc. | 494.88M | - | 957,543 | 89.40M |
| 223 | STRO | Sutro Biopharma, Inc. | 490.98M | - | 287,935 | 99.61M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 490.62M | - | 1,474,213 | - |
| 225 | ASMB | Assembly Biosciences, Inc. | 484.33M | - | 298,863 | 71.10M |
| 226 | ARTV | Artiva Biotherapeutics, Inc. | 477.14M | - | 1,747,772 | 251.00K |
| 227 | PRTA | Prothena Corporation plc | 467.51M | - | 1,390,844 | 57.94M |
| 228 | CABA | Cabaletta Bio, Inc. | 463.08M | - | 17,204,399 | - |
| 229 | CCCC | C4 Therapeutics, Inc. | 458.85M | - | 3,426,950 | 34.86M |
| 230 | MNPR | Monopar Therapeutics Inc. | 451.97M | - | 128,113 | - |
| 231 | CTNM | Contineum Therapeutics, Inc. | 446.39M | - | 313,870 | - |
| 232 | INDP | Indaptus Therapeutics, Inc. | 441.65M | - | 301,076 | - |
| 233 | FBRX | Forte Biosciences, Inc. | 436.18M | - | 228,693 | - |
| 234 | VTVT | vTv Therapeutics Inc. | 434.83M | - | 56,213 | 36.84M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 428.45M | - | 1,076,627 | 16.72M |
| 236 | OVID | Ovid Therapeutics Inc. | 423.67M | - | 15,348,112 | 7.12M |
| 237 | OCGN | Ocugen, Inc. | 419.77M | 0.81% | 26,269,780 | 4.47M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 417.47M | - | 471,611 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 417.41M | - | 154,630 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 413.01M | - | 579,840 | 109.16M |
| 241 | EDIT | Editas Medicine, Inc. | 412.81M | - | 3,286,390 | 38.69M |
| 242 | SGMT | Sagimet Biosciences Inc. | 412.50M | - | 3,592,541 | - |
| 243 | ANL | Adlai Nortye Ltd. | 404.00M | - | 42,964 | 5.00M |
| 244 | RGNX | REGENXBIO Inc. | 403.24M | - | 3,205,429 | 87.82M |
| 245 | AUTL | Autolus Therapeutics plc | 401.88M | -1.31% | 844,821 | 92.62M |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 398.03M | - | 866,269 | 9.01M |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 387.11M | - | 1,481,284 | - |
| 248 | PBYI | Puma Biotechnology, Inc. | 384.80M | - | 427,438 | 227.18M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 379.95M | - | 3,301,187 | - |
| 250 | STTK | Shattuck Labs, Inc. | 379.57M | - | 1,222,010 | 1.00M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 368.13M | - | 254,121 | 69.21M |
| 252 | NVCT | Nuvectis Pharma, Inc. | 366.58M | - | 323,637 | - |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 365.80M | 6.01% | 11,287,223 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 363.78M | - | 9,276,475 | 850.00K |
| 255 | VSTM | Verastem, Inc. | 362.04M | - | 4,766,027 | 49.59M |
| 256 | ZURA | Zura Bio Limited | 356.24M | - | 1,765,869 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 348.92M | - | 607,584 | - |
| 258 | VNDA | Vanda Pharmaceuticals Inc. | 348.79M | - | 1,729,045 | 217.78M |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 343.18M | - | 92,522 | - |
| 260 | UPB | Upstream Bio, Inc. | 340.12M | - | 829,656 | 3.32M |
| 261 | OABI | OmniAb, Inc. | 339.24M | - | 1,046,791 | 28.94M |
| 262 | CNXU | Conexeu Sciences Inc. | 335.59M | - | 36,289 | - |
| 263 | IRD | Opus Genetics, Inc. | 331.28M | - | 1,056,616 | 11.98M |
| 264 | ABEO | Abeona Therapeutics Inc. | 328.86M | - | 1,111,182 | 14.54M |
| 265 | SLN | Silence Therapeutics plc | 327.33M | - | 382,922 | 839.00K |
| 266 | PALI | Palisade Bio, Inc. | 324.59M | - | 4,040,405 | - |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 315.22M | - | 226,740 | - |
| 268 | FENC | Fennec Pharmaceuticals Inc. | 314.72M | - | 372,699 | 51.00M |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 311.87M | - | 1,484,537 | 1.00 |
| 270 | SABS | SAB Biotherapeutics, Inc. | 305.86M | - | 2,908,295 | 114.70K |
| 271 | ELDN | Eledon Pharmaceuticals, Inc. | 303.03M | - | 2,640,353 | - |
| 272 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | - | 1,697,954 | 14.78M |
| 273 | LYEL | Lyell Immunopharma, Inc. | 297.28M | - | 360,104 | 31.00K |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 289.74M | - | 475,585 | - |
| 275 | IVVD | Invivyd, Inc. | 285.74M | - | 21,078,803 | 55.87M |
| 276 | IMRX | Immuneering Corporation | 285.32M | - | 1,010,496 | - |
| 277 | RNAC | Cartesian Therapeutics, Inc. | 282.94M | - | 354,813 | 1.78M |
| 278 | NMRA | Neumora Therapeutics, Inc. | 279.78M | -1.31% | 2,200,626 | - |
| 279 | NAGE | Niagen Bioscience, Inc. | 279.34M | - | 952,868 | 130.42M |
| 280 | BCYC | Bicycle Therapeutics plc | 279.24M | - | 317,931 | 63.50M |
| 281 | SRZN | Surrozen, Inc. | 269.94M | - | 246,453 | 7.49M |
| 282 | IFRX | InflaRx N.V. | 266.60M | - | 1,494,163 | 33.82K |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 263.39M | - | 575,474 | 26.87M |
| 284 | MGNX | MacroGenics, Inc. | 262.52M | - | 973,000 | 157.08M |
| 285 | ADAG | Adagene Inc. | 260.33M | - | 169,928 | 7.67M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 259.80M | - | 21,260 | 5.20M |
| 287 | TRDA | Entrada Therapeutics, Inc. | 255.48M | - | 339,761 | 5.74M |
| 288 | AVXL | Anavex Life Sciences Corp. | 252.99M | - | 8,914,887 | - |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 246.54M | - | 6,101,106 | 80.00M |
| 290 | FHTX | Foghorn Therapeutics Inc. | 243.66M | - | 191,072 | 28.22M |
| 291 | FATE | Fate Therapeutics, Inc. | 243.61M | - | 4,122,848 | 6.32M |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 243.41M | - | 17,591 | 18.47M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 238.92M | - | 319,617 | 32.72M |
| 294 | ACIU | AC Immune SA | 238.08M | - | 213,331 | 4.62M |
| 295 | WHWK | Whitehawk Therapeutics, Inc. | 237.72M | - | 585,156 | 7.15M |
| 296 | CNTN | Canton Strategic Holdings, Inc. | 233.85M | - | 2,766,958 | - |
| 297 | HELP | Cybin Inc. | 233.67M | - | 455,994 | - |
| 298 | NGEN | NervGen Pharma Corp. | 233.65M | - | 1,487,007 | - |
| 299 | CDXS | Codexis, Inc. | 233.60M | 3.63% | 1,748,287 | 78.09M |
| 300 | CHRS | Coherus Oncology, Inc. | 228.29M | - | 1,288,484 | 46.88M |
| 301 | VYGR | Voyager Therapeutics, Inc. | 224.77M | - | 664,919 | 36.49M |
| 302 | TARA | Protara Therapeutics, Inc. | 223.69M | - | 803,711 | - |
| 303 | CLLS | Cellectis S.A. | 222.33M | - | 163,492 | 75.11M |
| 304 | RNA | Atrium Therapeutics, Inc. | 216.56M | - | 294,100 | 36.68M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 214.45M | - | 161,146 | 3.93M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 214.03M | - | 466,269 | 54.71M |
| 307 | KROS | Keros Therapeutics, Inc. | 210.78M | - | 400,525 | 33.18M |
| 308 | NERV | Minerva Neurosciences, Inc. | 208.25M | - | 574,968 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 205.88M | - | 5,048,972 | - |
| 310 | HUMA | Humacyte, Inc. | 205.23M | -4.59% | 11,323,184 | 2.02M |
| 311 | NKTX | Nkarta, Inc. | 204.62M | - | 569,310 | - |
| 312 | KPTI | Karyopharm Therapeutics Inc. | 204.42M | - | 492,124 | 151.12M |
| 313 | QTTB | Q32 Bio Inc. | 201.78M | - | 407,797 | 53.74M |
| 314 | PRQR | ProQR Therapeutics N.V. | 199.14M | - | 1,378,074 | 15.73M |
| 315 | ALEC | Alector, Inc. | 194.29M | - | 1,108,447 | 18.42M |
| 316 | IMUX | Immunic, Inc. | 193.43M | - | 263,741 | - |
| 317 | EQ | Equillium, Inc. | 192.84M | - | 424,579 | 4.39M |
| 318 | LENZ | LENZ Therapeutics, Inc. | 192.83M | - | 1,125,460 | 20.99M |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.45M | - | 567,366 | 17.56M |
| 320 | OTLK | Outlook Therapeutics, Inc. | 190.96M | -4.24% | 20,623,163 | 333.14K |
| 321 | CGEN | Compugen Ltd. | 190.12M | - | 503,835 | 72.66M |
| 322 | KRRO | Korro Bio, Inc. | 187.35M | - | 736,222 | 3.84M |
| 323 | GALT | Galectin Therapeutics Inc. | 186.05M | - | 336,750 | - |
| 324 | MDWD | MediWound Ltd. | 183.02M | - | 69,383 | 14.48M |
| 325 | UNCY | Unicycive Therapeutics, Inc. | 182.90M | - | 1,478,183 | - |
| 326 | OKUR | OnKure Therapeutics, Inc. | 180.97M | - | 1,651,378 | - |
| 327 | ANTX | AN2 Therapeutics, Inc. | 180.08M | - | 480,864 | - |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | - | 1,832,869 | 76.38M |
| 329 | MIST | Milestone Pharmaceuticals Inc. | 176.87M | -0.76% | 1,338,096 | 1.78M |
| 330 | DTIL | Precision BioSciences, Inc. | 175.71M | - | 431,067 | 45.07M |
| 331 | TTRX | Turn Therapeutics Inc. | 174.86M | - | 36,643 | - |
| 332 | NBP | NovaBridge Biosciences | 173.47M | - | 649,324 | - |
| 333 | IPHA | Innate Pharma S.A. | 173.04M | - | 1,668 | 10.57M |
| 334 | YDES | YD Bio Limited | 170.17M | - | 15,656 | 510.36K |
| 335 | HURA | TuHURA Biosciences, Inc. | 163.66M | - | 1,096,280 | - |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 163.23M | - | 696,851 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 162.66M | - | 2,539,773 | 11.20M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 158.79M | - | 149,667 | 2.00M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 158.54M | - | 2,551,532 | 225.00K |
| 340 | KZIA | Kazia Therapeutics Limited | 158.38M | - | 195,990 | 1.27M |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.04M | - | 297,815 | - |
| 342 | ACOG | Alpha Cognition Inc. | 150.46M | - | 25,621 | 10.83M |
| 343 | TLSA | Tiziana Life Sciences Ltd | 150.00M | - | 290,851 | - |
| 344 | ENLV | Enlivex Ltd. | 149.86M | - | 323,676 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 144.11M | - | 171,082 | 697.00K |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 143.70M | - | 778,383 | 2.29M |
| 347 | MOLN | Molecular Partners AG | 143.54M | - | 1,041 | 856.30K |
| 348 | ADCT | ADC Therapeutics SA | 138.64M | - | 1,725,034 | 79.18M |
| 349 | GUTS | Fractyl Health, Inc. | 136.17M | - | 1,410,510 | 3.00K |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 133.42M | - | 373,768 | 39.99K |
| 351 | SPRO | Spero Therapeutics, Inc. | 132.02M | 8.06% | 7,195,319 | 61.19M |
| 352 | GNLX | Genelux Corporation | 131.67M | - | 98,794 | 8.00K |
| 353 | CGTX | Cognition Therapeutics, Inc. | 129.77M | 2.11% | 1,303,647 | - |
| 354 | PYXS | Pyxis Oncology, Inc. | 128.61M | - | 668,653 | 13.86M |
| 355 | CNTB | Connect Biopharma Holdings Limited | 125.93M | - | 204,208 | 233.00K |
| 356 | AGEN | Agenus Inc. | 124.93M | - | 868,396 | 123.87M |
| 357 | PEPG | PepGen Inc. | 123.81M | - | 692,233 | - |
| 358 | ALPS | Alps Group Inc | 119.81M | - | 20,517 | 3.74M |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 118.23M | - | 2,185,078 | - |
| 360 | MENS | Jyong Biotech Ltd. | 115.80M | - | 120,950 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 115.41M | - | 215,714 | 7.94M |
| 362 | ENGN | enGene Therapeutics Inc. | 115.22M | - | 885,200 | - |
| 363 | CUE | Cue Biopharma, Inc. | 115.14M | - | 197,840 | 32.73M |
| 364 | ONCY | Oncolytics Biotech Inc. | 114.58M | 3.03% | 1,129,424 | - |
| 365 | VRXA | Veraxa Biotech AG | 112.97M | - | 772,288 | - |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 112.30M | - | 235,548 | - |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 109.84M | - | 105,769 | - |
| 368 | CBUS | Cibus, Inc. | 103.81M | - | 808,226 | 4.29M |
| 369 | PTHS | Pelthos Therapeutics Inc. | 100.79M | - | 46,219 | 27.70M |
| 370 | FBIO | Fortress Biotech, Inc. | 99.33M | - | 372,256 | 66.16M |
| 371 | VANI | Vivani Medical, Inc. | 99.17M | - | 201,861 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 99.01M | 8.18% | 600,837 | - |
| 373 | TELO | Telomir Pharmaceuticals, Inc. | 97.66M | - | 1,130,331 | - |
| 374 | RANI | Rani Therapeutics Holdings, Inc. | 96.93M | - | 308,786 | 3.17M |
| 375 | VRCA | Verrica Pharmaceuticals Inc. | 96.72M | - | 26,786 | 37.16M |
| 376 | SEER | Seer, Inc. | 95.67M | - | 102,096 | 15.17M |
| 377 | BDTX | Black Diamond Therapeutics, Inc. | 95.12M | - | 1,909,190 | 70.00M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 94.52M | - | 5,928 | - |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 91.73M | - | 2,757,454 | 65.34K |
| 380 | ATHE | Alterity Therapeutics Limited | 91.50M | - | 19,285 | 4.43M |
| 381 | PYPD | PolyPid Ltd. | 90.89M | - | 101,277 | - |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 90.73M | - | 144,866 | 23.14M |
| 383 | NRXS | NeurAxis, Inc. | 88.55M | - | 164,453 | 4.28M |
| 384 | LIXT | Lixte Biotechnology Holdings, Inc. | 88.41M | - | 1,007,714 | - |
| 385 | CSBR | Champions Oncology, Inc. | 87.76M | - | 5,178 | 57.95M |
| 386 | OSTX | OS Therapies Incorporated | 85.96M | - | 1,145,109 | - |
| 387 | ICCC | ImmuCell Corporation | 85.85M | - | 34,226 | 29.93M |
| 388 | AARD | Aardvark Therapeutics, Inc. | 85.74M | - | 152,743 | - |
| 389 | BMEA | Biomea Fusion, Inc. | 85.31M | - | 744,070 | - |
| 390 | RNTX | Rein Therapeutics Inc. | 85.20M | - | 2,056,659 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 85.12M | - | 1,381,153 | - |
| 392 | ACET | Adicet Bio, Inc. | 85.06M | - | 36,383 | - |
| 393 | RLYB | Rallybio Corporation | 84.48M | - | 28,972 | 858.00K |
| 394 | IBIO | iBio, Inc. | 83.96M | - | 912,081 | 300.00K |
| 395 | OKYO | OKYO Pharma Limited | 83.44M | - | 65,087 | - |
| 396 | CRDF | Cardiff Oncology, Inc. | 82.73M | - | 960,682 | 525.00K |
| 397 | GOSS | Gossamer Bio, Inc. | 82.13M | - | 23,415,698 | 55.54M |
| 398 | GANX | Gain Therapeutics, Inc. | 80.19M | - | 503,933 | - |
| 399 | HRTX | Heron Therapeutics, Inc. | 79.02M | - | 5,463,114 | 150.71M |
| 400 | LONA | LeonaBio, Inc. | 76.84M | - | 8,646 | - |
| 401 | HYFT | MindWalk Holdings Corp. | 75.99M | - | 269,698 | 20.70M |
| 402 | ANVS | Annovis Bio, Inc. | 74.45M | - | 1,091,219 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 71.83M | - | 472,904 | - |
| 404 | ELTX | Elicio Therapeutics, Inc. | 70.82M | -18.26% | 5,435,699 | - |
| 405 | XBIT | XBiotech Inc. | 70.43M | - | 40,396 | - |
| 406 | IMA | ImageneBio, Inc. | 67.67M | - | 34,301 | 800.00K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 67.20M | - | 713,718 | - |
| 408 | KALA | KALA BIO, Inc. | 67.11M | - | 959,164 | - |
| 409 | EXOZ | eXoZymes, Inc. | 66.39M | - | 20,019 | -700.00 |
| 410 | CING | Cingulate Inc. | 66.25M | - | 506,498 | - |
| 411 | BYSI | BeyondSpring Inc. | 66.20M | - | 35,146 | 1.88M |
| 412 | EDSA | Edesa Biotech, Inc. | 65.36M | 6.83% | 258,618 | - |
| 413 | MNOV | MediciNova, Inc. | 64.97M | - | 34,841 | 596.64K |
| 414 | MCRB | Seres Therapeutics, Inc. | 64.01M | - | 124,619 | 1.15M |
| 415 | INKT | MiNK Therapeutics, Inc. | 60.48M | - | 16,573 | - |
| 416 | PMVP | PMV Pharmaceuticals, Inc. | 60.26M | - | 242,605 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 60.12M | - | 447,810 | 9.14M |
| 418 | ENTX | Entera Bio Ltd. | 59.56M | - | 51,008 | 42.00K |
| 419 | FLNA | Filana Therapeutics, Inc. | 58.94M | - | 465,034 | - |
| 420 | CNTX | Context Therapeutics Inc. | 58.06M | - | 3,143,716 | - |
| 421 | ELOX | Eloxx Pharmaceuticals, Inc. | 56.43M | - | 38,574 | - |
| 422 | IMMP | Immutep Limited | 54.76M | - | 240,241 | 5.28M |
| 423 | IBO | Impact BioMedical Inc. | 54.15M | - | 105,866 | 39.00K |
| 424 | PDSB | PDS Biotechnology Corporation | 53.30M | - | 457,558 | - |
| 425 | XLO | Xilio Therapeutics, Inc. | 52.59M | - | 56,750 | 53.48M |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 52.13M | - | 74,860 | - |
| 427 | TIL | Instil Bio, Inc. | 50.86M | - | 22,519 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 49.70M | - | 17,177 | 10.86M |
| 429 | ACTU | Actuate Therapeutics, Inc. | 49.53M | - | 100,514 | - |
| 430 | MREO | Mereo BioPharma Group plc | 49.39M | - | 1,440,204 | 500.00K |
| 431 | HYPD | Hyperion DeFi, Inc. | 49.01M | - | 821,717 | 1.04M |
| 432 | LTRN | Lantern Pharma Inc. | 48.36M | - | 209,028 | - |
| 433 | VERU | Veru Inc. | 47.35M | - | 573,734 | 16.89M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 45.18M | - | 190,432 | 22.33M |
| 435 | ATYR | aTyr Pharma, Inc. | 44.17M | - | 1,533,392 | 190.00K |
| 436 | RNXT | RenovoRx, Inc. | 41.49M | - | 330,617 | 1.49M |
| 437 | ESLA | Estrella Immunopharma, Inc. | 40.88M | - | 51,505 | - |
| 438 | GNTA | Genenta Science S.p.A. | 39.63M | -8.70% | 138,837 | - |
| 439 | TVGN | Tevogen Bio Holdings Inc. | 39.61M | - | 13,178 | - |
| 440 | CRVO | CervoMed Inc. | 39.26M | 11.29% | 107,909,165 | 2.09M |
| 441 | GRCE | Grace Therapeutics, Inc. | 38.73M | - | 280,313 | - |
| 442 | INMB | INmune Bio Inc. | 38.55M | - | 446,953 | 50.00K |
| 443 | APLM | Apollomics, Inc. | 38.43M | - | 45,632 | 8.84M |
| 444 | GRDX | GridAI Technologies Corp. | 35.93M | - | 181,398 | - |
| 445 | NTRB | Nutriband Inc. | 35.25M | - | 29,194 | 1.80M |
| 446 | ABVC | ABVC BioPharma, Inc. | 34.11M | - | 77,038 | 797.92K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.67M | - | 39,806 | 4.71M |
| 448 | DARE | Daré Bioscience, Inc. | 32.51M | - | 179,599 | 1.16M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 32.32M | - | 130,679 | 90.00K |
| 450 | BOLD | Boundless Bio, Inc. | 32.12M | - | 80,382 | - |
| 451 | LSTA | Lisata Therapeutics, Inc. | 32.05M | - | 41,517 | 170.00K |
| 452 | NNVC | NanoViricides, Inc. | 31.89M | - | 262,206 | - |
| 453 | SER | Serina Therapeutics, Inc. | 31.29M | - | 187,680 | 130.00K |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 29.02M | - | 114,919 | 38.00K |
| 455 | PSTV | Plus Therapeutics, Inc. | 28.91M | - | 214,522 | 5.18M |
| 456 | DYAI | Dyadic International, Inc. | 28.50M | - | 217,456 | 3.81M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 28.44M | - | 241,043 | - |
| 458 | LITS | Lite Strategy, Inc. | 28.17M | - | 602,336 | - |
| 459 | VTGN | Vistagen Therapeutics, Inc. | 27.50M | - | 1,085,104 | 1.27M |
| 460 | IGC | IGC Pharma, Inc. | 27.16M | - | 631,197 | 1.11M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.12M | - | 15,595 | 7.44M |
| 462 | BRNS | Barinthus Biotherapeutics plc | 27.05M | - | 8,160 | 14.97M |
| 463 | LGVN | Longeveron Inc. | 25.54M | -2.37% | 240,915 | 1.22M |
| 464 | EVAX | Evaxion A/S | 25.44M | - | 42,455 | 7.53M |
| 465 | BCTX | BriaCell Therapeutics Corp. | 25.22M | - | 54,650 | - |
| 466 | PLRZ | Polyrizon Ltd. | 25.12M | - | 66,731 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 24.86M | - | 157,161 | - |
| 468 | TVRD | Tvardi Therapeutics, Inc. | 24.67M | - | 103,629 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 24.37M | - | 166,356 | - |
| 470 | FTH | Faeth Therapeutics, Inc. | 23.91M | - | 66,039 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 23.29M | - | 150,571 | -13.27K |
| 472 | ALLR | Allarity Therapeutics, Inc. | 22.75M | - | 297,932 | 345.00K |
| 473 | CLRB | Cellectar Biosciences, Inc. | 22.30M | - | 299,803 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 22.18M | - | 46,576 | 3.55M |
| 475 | PLUR | Pluri Inc. | 21.79M | - | 40,297 | 1.08M |
| 476 | CELU | Celularity Inc. | 21.78M | - | 47,584 | 26.55M |
| 477 | PTN | Palatin Technologies, Inc. | 21.74M | - | 12,888 | 12.88M |
| 478 | VYNE | VYNE Therapeutics Inc. | 21.17M | - | 247,843 | 454.00K |
| 479 | LPCN | Lipocine Inc. | 19.21M | - | 122,356 | 2.00M |
| 480 | GTBP | GT Biopharma, Inc. | 18.54M | - | 1,977,633 | - |
| 481 | TPST | Tempest Therapeutics, Inc. | 18.21M | - | 51,026 | - |
| 482 | CVM | CEL-SCI Corporation | 18.18M | - | 524,279 | - |
| 483 | PASG | Passage Bio, Inc. | 17.93M | - | 73,070 | - |
| 484 | NCEL | NewcelX Ltd. | 17.82M | - | 15,299 | - |
| 485 | AEON | AEON Biopharma, Inc. | 17.57M | - | 60,374 | - |
| 486 | ATOS | Atossa Therapeutics, Inc. | 17.31M | - | 193,503 | - |
| 487 | LNAI | Lunai Bioworks Inc. | 17.14M | - | 1,042,826 | 20.94K |
| 488 | HOWL | Werewolf Therapeutics, Inc. | 17.07M | - | 1,575,775 | 1.14M |
| 489 | MLEC | Moolec Science SA | 17.02M | - | 70,288 | 7.83M |
| 490 | CRIS | Curis, Inc. | 16.83M | - | 898,606 | 7.06M |
| 491 | KTTA | Pasithea Therapeutics Corp. | 16.71M | - | 196,337 | - |
| 492 | QNCX | Quince Therapeutics, Inc. | 15.41M | - | 736,595 | - |
| 493 | MBRX | Moleculin Biotech, Inc. | 15.37M | - | 379,153 | - |
| 494 | HIND | Vyome Holdings, Inc. | 15.23M | - | 26,369 | 152.72K |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 15.00M | - | 256,914 | 5.61M |
| 496 | XCUR | Exicure, Inc. | 14.72M | - | 53,022 | 500.00K |
| 497 | BLRX | BioLineRx Ltd. | 14.15M | - | 7,860 | 1.40M |
| 498 | INAB | IN8bio, Inc. | 14.08M | - | 52,942 | - |
| 499 | OSRH | OSR Holdings, Inc. | 13.75M | 1.98% | 816,229 | 2.63M |
| 500 | COCP | Cocrystal Pharma, Inc. | 13.72M | - | 74,320 | 225.00K |